All genes were expressed in more than 70% of the CRC patients with CEA, CK19, and REG4 expressed in 77.8%, TIAM1, and uPA expressed in 74%, while CK20 expressed in 70.4% of the patients. This evidence concerns the gene CEACAM5 and colorectal carcinoma.